Gnrh670 发表于 2025-3-28 15:15:43

http://reply.papertrans.cn/23/2206/220547/220547_41.png

syncope 发表于 2025-3-28 22:20:04

Introduction,development of the field of cell-penetrating peptides in these five years has been obvious and exciting. Multiple novel mechanisms and applications of the CPPs have been demonstrated, leading to the better understanding of the possibilities to understand the Nature and possible novel drug possibilit

EXULT 发表于 2025-3-29 01:08:20

http://reply.papertrans.cn/23/2206/220547/220547_43.png

只有 发表于 2025-3-29 05:59:05

http://reply.papertrans.cn/23/2206/220547/220547_44.png

Embolic-Stroke 发表于 2025-3-29 08:00:36

Book 2023Latest editiontions for further development. The CPP sequences are presented and discussed throughout the book. The methods for testing CPP mechanisms are discussed in detail. Various approaches for the testing of endocytotic pathways of CPP uptake are also described. Different CPP uptake experiments are compared

忙碌 发表于 2025-3-29 14:02:43

used for CPP studies and applications.In this book, a summary and update of the most important areas of cell-penetrating peptides (CPP) research are presented, while raising relevant questions for further development. The CPP sequences are presented and discussed throughout the book. The methods for

nepotism 发表于 2025-3-29 17:55:08

http://reply.papertrans.cn/23/2206/220547/220547_47.png

暂停,间歇 发表于 2025-3-29 19:59:20

Concluding Remarks,icles (LNP) seems to yield successful drug delivery systems. The surface of a nanoparticle is suitable for tethering by CPPs and/or targeting peptides, yielding transmembrane targeted delivery of the added cargo. Vaccine developments using the CPP-aided delivery methods become more popular.

inchoate 发表于 2025-3-29 23:52:53

http://reply.papertrans.cn/23/2206/220547/220547_49.png

低三下四之人 发表于 2025-3-30 05:39:29

http://reply.papertrans.cn/23/2206/220547/220547_50.png
页: 1 2 3 4 [5] 6
查看完整版本: Titlebook: CPP, Cell-Penetrating Peptides; Ülo Langel Book 2023Latest edition The Editor(s) (if applicable) and The Author(s), under exclusive licens